Meningococcal Vaccines Market, By Vaccine Type, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Meningitis is an inflammation in the inner lining of the brain and spinal cord that results from infectious (viral, bacterial, and rarely fungal) or non-infectious (drugs, sarcoidosis etc.) factors. The swelling associated with meninges triggers symptoms such as painful headaches, fever, loss of appetite, and stiffness of the neck. Meningitis is a fatal disease and has a rapid onset of action. Meningitis can cause severe damage to the brain in almost half of the total infected population, if untreated. It can also lead to serious ailments such as mental retardation, epilepsy, and deafness. According to Meningitis Research Foundation, as of 2017, around 80% - 90% of meningitis cases are estimated to be caused by enteroviruses and the remaining 10% is estimated to be caused by herpes virus, mumps, measles, and human immune deficiency virus.

Restraints of the Global Meningococcal Vaccines Market

High cost of meningococcal vaccination and low coverage of the same are expected to hinder growth of the global meningococcal vaccines market.

Key features of the study:

• This report provides in-depth analysis of the global meningococcal vaccines market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global meningococcal vaccines market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Baxter International, Inc., Biomed Pvt. Ltd., GlaxoSmithKline plc, JN-International Medical Corporation, Novartis International AG., Pfizer, Inc., Sanofi SA, and Serum Institute of India Ltd.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global meningococcal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

• Global Meningococcal Vaccines Market, By Vaccine Type:
  • Polysaccharide
  • Conjugate
  • Combination
• Global Meningococcal Vaccines Market, By Distribution Channel:
  • Government
  • Private
• Global Meningococcal Vaccines Market, By Geography:
  • North America
  • By Vaccine Type
• Polysaccharide
• Conjugate
• Combination
  • By Distribution Channel
• Government
• Private
  • By Country:
• U.S.
• Canada
  • Europe
  • By Vaccine Type
• Polysaccharide
• Conjugate
• Combination
  • By Distribution Channel
• Government
• Private
  • By Country:
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
  • Asia Pacific
  • By Vaccine Type
• Polysaccharide
• Conjugate
• Combination
  • By Distribution Channel
• Government
• Private
  • By Country:
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
  • Latin America
  • By Vaccine Type
• Polysaccharide
• Conjugate
• Combination
  • By Distribution Channel
• Government
• Private
  • By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
  • Middle East:
  • By Vaccine Type
• Polysaccharide
• Conjugate
• Combination
  • By Distribution Channel
• Government
• Private
  • By Country:
• GCC
• Israel
• Rest of Middle East
  • Africa
  • By Vaccine Type
• Polysaccharide
• Conjugate
• Combination
  • By Distribution Channel
• Government
• Private
  • By Country/Region:
• Central Africa
• South Africa
• North Africa
• Company Profiles
  • Baxter International, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Biomed Pvt. Ltd.
  • GlaxoSmithKline plc
  • JN-International Medical Corporation
  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi SA
  • Serum Institute of India Ltd.

"*" marked represents similar segmentation in other categories in the respective section.